Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
Monte Rosa Therapeutics, Inc
Duke University
AstraZeneca
Sapience Therapeutics
Memorial Sloan Kettering Cancer Center
University of Maryland, Baltimore
Dana-Farber Cancer Institute
Medstar Health Research Institute
Fred Hutchinson Cancer Center
Swiss Cancer Institute
Complement Theory Inc.
City of Hope Medical Center
University of Southern California
NeoTX Therapeutics Ltd.
UNICANCER
National Cancer Institute (NCI)
Pfizer
Vanderbilt-Ingram Cancer Center
University of Colorado, Denver
Eli Lilly and Company
University of Alabama at Birmingham
University College, London
Memorial Sloan Kettering Cancer Center
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Theratechnologies
Memorial Sloan Kettering Cancer Center
Carisma Therapeutics Inc
University of Toronto
Region Örebro County
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc